Syntis Bio raises $33 million in Series A funding to advance its oral SYNT platform, including SYNT-101 for obesity and SYNT-202 for rare disease. With additional NIH grant support, the company aims to transform weight loss and metabolic health treatment through non-invasive drug delivery.

The Health and Fitness Association expresses disappointment after the Senate-passed reconciliation bill excludes the physical activity HSA provision. Modeled on the bipartisan PHIT Act, the measure would have allowed Americans to use pre-tax dollars for fitness expenses—supporting preventive care, reducing healthcare costs, and making healthy living more accessible.

World Gym International signs a Master Franchise Agreement with Flag Holding LTDA to expand to 50 locations in Brazil, marking a major step in the brand’s global growth strategy.